Cargando…
Vascular targeted photodynamic therapy: A review of the efforts towards molecular targeting of tumor vasculature
The therapeutic value of vascular targeted photodynamic therapy (VTP) for cancer has already been recognized in the clinic: TOOKAD(®) has been clinically approved in Europe and Israel for treatment of men with low-risk prostate cancer. When light is applied shortly after intravenous administration o...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116708/ https://www.ncbi.nlm.nih.gov/pubmed/33568892 http://dx.doi.org/10.1142/s1088424619300180 |